Announcement

Collapse
No announcement yet.

Cureus . A Rare Case of Empyema Complicated With Bronchopleural Fistula Secondary to Mucormycosis in a Young Immunocompromised Diabetic Patient With COVID-19

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • Cureus . A Rare Case of Empyema Complicated With Bronchopleural Fistula Secondary to Mucormycosis in a Young Immunocompromised Diabetic Patient With COVID-19


    Cureus


    . 2022 Jul 7;14(7):e26635.
    doi: 10.7759/cureus.26635. eCollection 2022 Jul.
    A Rare Case of Empyema Complicated With Bronchopleural Fistula Secondary to Mucormycosis in a Young Immunocompromised Diabetic Patient With COVID-19


    Ruby Risal 1 , Tahmina Jahir 1 , Ratul Islam 2 , Pharlin Noel 3 , Kamal R Subedi 4 , Ahmad Khan 1 , Aneeta Kumari 5 , Marie Schmidt 1



    Affiliations

    Abstract

    Mucormycosis is an opportunistic fungal infection caused by the zygomycetes Mucor and Rhizopus. Most documented conditions and risk factors that predispose to mucormycosis are uncontrolled diabetes mellitus (DM), with or without ketoacidosis, hematological malignancies (HM), transplantation, immunosuppression, and chronic sinusitis. Pulmonary empyema secondary to Mucor in coronavirus disease 2019 (COVID-19)-infected patients is rarely documented. Here we present an extremely rare case of pulmonary empyema secondary to Mucor infection complicated by bronchocutaneous fistula in a human immunodeficiency virus (HIV)-infected patient in the setting of acute COVID-19 infection.

    Keywords: covid 19; diabetic ketoacidosis (dka); empyema necessitans; “diabetes mellitus”; “mucormycosis”.



    Copyright © 2022, Risal et al.
Working...
X